Skip to main content
Veterinary Medicines

PANVERMIN ORAL 150 mg/g polvo para solucion oral para bovino, ovino, porcino y aves

Authorised
  • Levamisole hydrochloride

Product identification

Medicine name:
PANVERMIN ORAL 150 mg/g polvo para solucion oral para bovino, ovino, porcino y aves
Active substance:
  • Levamisole hydrochloride
Target species:
  • Cattle
  • Sheep
  • Pig
  • Birds
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    176.80
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        14
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        14
        day
    • Birds
      • Meat and offal
        7
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Syva S.A.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 349 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 1/02/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 1/02/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 1/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."